News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
57,238 Results
Type
Article (6266)
Company Profile (13)
Press Release (50959)
Section
Business (14707)
Career Advice (50)
Deals (2253)
Drug Delivery (11)
Drug Development (12050)
Employer Resources (13)
FDA (1911)
Job Trends (2233)
News (30361)
Policy (4996)
Tag
Academia (361)
Alliances (4965)
Alzheimer's disease (117)
Approvals (1936)
Bankruptcy (28)
Best Places to Work (2085)
Breast cancer (18)
Cancer (177)
Career advice (47)
CAR-T (19)
Cell therapy (45)
Clinical research (8492)
Collaboration (73)
COVID-19 (2026)
C-suite (20)
Data (191)
Diagnostics (370)
Earnings (4706)
Employer resources (12)
Events (6681)
Executive appointments (41)
FDA (2057)
Funding (52)
Gene therapy (26)
GLP-1 (66)
Government (1798)
Healthcare (1720)
Immunology and inflammation (12)
Infectious disease (2116)
Inflammatory bowel disease (17)
Influenza (38)
IPO (992)
Job creations (288)
Job search strategy (47)
Layoffs (67)
Legal (479)
Lung cancer (13)
Lymphoma (17)
Manufacturing (40)
Medical device (362)
Medtech (362)
Mergers & acquisitions (1286)
Metabolic disorders (24)
Multiple sclerosis (12)
Neuroscience (145)
NextGen: Class of 2025 (334)
Non-profit (331)
Northern California (118)
Obesity (11)
Opinion (29)
Ovarian cancer (15)
Patents (21)
People (4256)
Phase I (3026)
Phase II (3527)
Phase III (3203)
Pipeline (88)
Podcasts (12)
Policy (22)
Postmarket research (385)
Preclinical (1168)
Press Release (19)
Rare diseases (29)
Real estate (484)
Regulatory (3184)
Reports (11)
Research institute (378)
RSV (44)
Southern California (117)
Startups (269)
The Weekly (12)
United States (1617)
Vaccines (725)
Weight loss (14)
Date
Today (13)
Last 7 days (61)
Last 30 days (246)
Last 365 days (3085)
2025 (455)
2024 (3143)
2023 (3752)
2022 (6872)
2021 (7810)
2020 (6266)
2019 (2774)
2018 (2123)
2017 (2121)
2016 (2107)
2015 (2561)
2014 (1987)
2013 (1618)
2012 (1811)
2011 (1950)
2010 (1810)
Location
Africa (161)
Alabama (16)
Asia (3916)
Australia (616)
California (282)
Canada (136)
China (29)
Connecticut (18)
Delaware (12)
Europe (9272)
Florida (36)
Georgia (34)
Illinois (16)
Indiana (23)
Japan (16)
Maryland (266)
Massachusetts (218)
New Jersey (277)
New York (135)
North Carolina (48)
Northern California (118)
Pennsylvania (120)
South America (97)
Southern California (117)
Texas (30)
Washington State (36)
57,238 Results for "eurocine vaccines".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
FDA Issues Back-to-Back Vaccine Approvals as RFK Jr. Takes HHS Seat
The approvals come as Robert F. Kennedy Jr.—who has been critical of vaccines—takes leadership of the Department of Health and Human Services.
February 17, 2025
·
2 min read
·
Tristan Manalac
Outstanding results for Eurocine Vaccines´ mRNA based HSV-2 candidate
As communicated earlier, Eurocine Vaccines is conducting preclinical trials to evaluate the mRNA and protein technology platforms for its therapeutic Herpes simplex virus type 2, HSV-2, vaccine candidates.
December 20, 2022
·
2 min read
Business
Eurocine Vaccines expands its portfolio with a therapeutic HSV-2 vaccine candidate
Eurocine Vaccines AB (“Eurocine Vaccines”) hereby announces that the company has entered into a research and collaboration agreement with Redbiotec AG (“Redbiotec”).
June 14, 2022
·
3 min read
Vaccines
Meeting of FDA’s Vaccines Advisory Panel Canceled as Kennedy Settles Into HHS
The back-to-back high-level disruptions in vaccine policy under Robert F. Kennedy Jr. comes as the U.S. records its first death from measles since 2015.
February 27, 2025
·
2 min read
·
Tristan Manalac
Vaccines
CDC Vaccine Advisory Board Meeting Postponed Days After RFK Jr. Confirmation
The postponed ACIP meeting comes barely a week after Robert F. Kennedy, Jr. was confirmed as Secretary of Health and Human Services, despite controversy regarding his anti-vaccine history.
February 21, 2025
·
2 min read
·
Tristan Manalac
Government
RFK Jr. Again Faces Scrutiny Over Vaccines on Day 2 of Confirmation Hearing
Senators on the Health, Education, Labor and Pensions committee were critical of Kennedy’s long history as an anti-vaccine campaigner.
January 31, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Sanofi Hit With $250M Impairment After Scrapping J&J-Partnered
E. coli
Vaccine
Without providing specific data, Sanofi on Thursday announced that the experimental vaccine did not significantly prevent invasive
E. coli
disease versus placebo.
February 13, 2025
·
2 min read
·
Tristan Manalac
Earnings
Sanofi Earnings Driven by Dupixent, New RSV Vaccine as Hunt for Deals Continues
Sanofi’s jump in earnings comes with an increased emphasis on R&D and vaccines, plus an eye cast toward M&A to shore up its pipeline.
January 30, 2025
·
2 min read
·
Dan Samorodnitsky
Vaccines
Moderna Nabs Another $590M from HHS for mRNA-Based Bird Flu Vaccines
The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready before bird flu strains currently circulating in the wild and on farms can potentially cause human outbreaks.
January 21, 2025
·
1 min read
·
Dan Samorodnitsky
Eurocine Vaccines´ Adjuvant Technology Endocine™ is evaluated with a vaccine candidate against COVID-19
Eurocine Vaccines has signed a Material Transfer Agreement regarding the evaluation of Endocine™ together with a vaccine candidate against COVID-19
May 19, 2021
·
1 min read
1 of 5,724
Next
